BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26347720)

  • 1. Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria.
    Rios-Covian D; Sánchez B; Salazar N; Martínez N; Redruello B; Gueimonde M; de Los Reyes-Gavilán CG
    Front Microbiol; 2015; 6():825. PubMed ID: 26347720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.
    Rios-Covian D; Cuesta I; Alvarez-Buylla JR; Ruas-Madiedo P; Gueimonde M; de Los Reyes-Gavilán CG
    BMC Microbiol; 2016 Jul; 16(1):150. PubMed ID: 27418149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.
    Rios-Covian D; Arboleya S; Hernandez-Barranco AM; Alvarez-Buylla JR; Ruas-Madiedo P; Gueimonde M; de los Reyes-Gavilan CG
    Appl Environ Microbiol; 2013 Dec; 79(23):7518-24. PubMed ID: 24077708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture.
    Rios-Covián D; Sánchez B; Martínez N; Cuesta I; Hernández-Barranco AM; de Los Reyes-Gavilán CG; Gueimonde M
    Can J Microbiol; 2016 Jul; 62(7):623-8. PubMed ID: 27156738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro.
    Liu G; Chen H; Chen J; Wang X; Gu Q; Yin Y
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1693-1702. PubMed ID: 30569218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effect of exopolysaccharides from Bifidobacterium bifidum WBIN03 on microbial diversity in mouse intestine.
    Li S; Chen T; Xu F; Dong S; Xu H; Xiong Y; Wei H
    J Sci Food Agric; 2014 Jan; 94(2):256-64. PubMed ID: 23716082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of exopolysaccharides by Lactobacillus and Bifidobacterium strains of human origin, and metabolic activity of the producing bacteria in milk.
    Salazar N; Prieto A; Leal JA; Mayo B; Bada-Gancedo JC; de los Reyes-Gavilán CG; Ruas-Madiedo P
    J Dairy Sci; 2009 Sep; 92(9):4158-68. PubMed ID: 19700676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans.
    Pudlo NA; Urs K; Kumar SS; German JB; Mills DA; Martens EC
    mBio; 2015 Nov; 6(6):e01282-15. PubMed ID: 26556271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories.
    Cordovana M; Kostrzewa M; Sóki J; Witt E; Ambretti S; Pranada AB
    Anaerobe; 2018 Dec; 54():246-253. PubMed ID: 29626622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study.
    Del Piano M; Balzarini M; Carmagnola S; Pagliarulo M; Tari R; Nicola S; Deidda F; Pane M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S56-61. PubMed ID: 25291130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of the bacterial steroid degradation for the etiology of large bowel cancer. V. Transformation of chenodeoxycholic acid by saccharolytic bacteroides-species (author's transl)].
    Edenharder R; Stubenrauch S; Slemrova J
    Zentralbl Bakteriol Orig B; 1976 Aug; 162(5-6):506-18. PubMed ID: 983545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of Surface Exopolysaccharides From
    Castro-Bravo N; Wells JM; Margolles A; Ruas-Madiedo P
    Front Microbiol; 2018; 9():2426. PubMed ID: 30364185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Symbiont
    Chatzidaki-Livanis M; Coyne MJ; Roelofs KG; Gentyala RR; Caldwell JM; Comstock LE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
    Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
    Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation by fragilis and non-fragilis Bacteroides strains in vitro.
    Blake M; Rotstein OD; Llano M; Girotti MJ; Reid G
    J Med Microbiol; 1989 Jan; 28(1):9-14. PubMed ID: 2536442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Fifth Antibacterial Toxin Produced by a Single Bacteroides fragilis Strain.
    Shumaker AM; Laclare McEneany V; Coyne MJ; Silver PA; Comstock LE
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30692177
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a growth medium suitable for exopolysaccharide production and structural characterisation by Bifidobacterium animalis ssp. lactis AD011.
    Alhudhud M; Humphreys P; Laws A
    J Microbiol Methods; 2014 May; 100():93-8. PubMed ID: 24632517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential role of fumarate reductase in haem-dependent growth stimulation of Bacteroides fragilis.
    Baughn AD; Malamy MH
    Microbiology (Reading); 2003 Jun; 149(Pt 6):1551-1558. PubMed ID: 12777495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.